Global Bioanalytical Testing Services Market Get over US$ 4.57 billion by 2020-2027
According to the Acumen Research and Consulting, the global Bioanalytical Testing Services market is expected to reach at US$ 4.57 billion by 2026, along with the projected CAGR of 7 % from 2020-2026.
The published report global Bioanalytical Testing Services market provides a holistic overview of the current market covering the current trends. The provided quantitative and qualitative data is based on the deeper analysis of the historical data and the current market situation that helps to provide an overview of the forecasted period.
Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1301
The global Bioanalytical Testing Services market report provides deeper insights on the factors driving the global market along with the factors that are responsible to hamper the growth. In addition, the report provides the opportunities in the global Bioanalytical Testing Services market that would help the competitors to increase the profit share.
The global Bioanalytical Testing Services market report provides the quantitative information of the target segment that is covered in the report along with the regional data comparison.
The report provides an overview value chain analysis, Porters Five analysis, and cost structure analysis gives an idea of the industrial outlook. The global Bioanalytical Testing Services market report covers the data of the major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the report also covers the country cross section providing deeper insights of the particular region.
The published global Bioanalytical Testing Services market report provides information about the major players operating in the target market. The company profile section provides important information about the major players, along with the financial overview, product segment revenue, the geographical presence of the company. It also provides information related to business development activities by the players such as merger & acquisition, partnerships and agreements.
The global Bioanalytical Testing Services market report also covers the products information that is offered by the particular players along with the specification. In addition, the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.
Market participants
PSC, SGS SA, Toxikon, Inc., The Intertech group, Pace Analytical Services, SLC, PPD ; ICON plc ; Covance Inc. ; LabCorp ; Charles River Laboratories International, Inc.. among others
Market segmentation
Bioanalytical Testing Services Market by Molecule Type
- Large Molecule
- Immunoassays
- LC-MS Studies
- Others
- Small Molecule
Bioanalytical Testing Services Market by Test Type
- ADME
- In-Vitro
- In-Vivo
- PD
- PK
- Bioequivalence
- Bioavailability
- Others
Global Bioanalytical Testing Services Market, by Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
Table of content
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Bioanalytical Testing Services
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Bioanalytical Testing Services Market By Molecule Type
1.2.2.1. Global Bioanalytical Testing Services Market Revenue and Growth Rate Comparison By Molecule Type (2015-2026)
1.2.2.2. Global Bioanalytical Testing Services Market Revenue Share By Molecule Type in 2017
1.2.2.3. Large Molecule
1.2.2.3.1. Immunoassays
1.2.2.3.2. LC-MS Studies
1.2.2.3.3. Others
1.2.2.4. Small Molecule
1.2.2.5. Others
1.2.3. Bioanalytical Testing Services Market By Test Type
1.2.3.1. Global Bioanalytical Testing Services Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.3.2. Global Bioanalytical Testing Services Market Revenue Share By Test Type in 2017
1.2.3.3. ADME
1.2.3.3.1. In-Vitro
1.2.3.3.2. In-Vivo
1.2.3.4. PD
1.2.3.5. PK
1.2.3.6. Bioequivalence
1.2.3.7. Bioavailability
1.2.3.8. Others
1.2.4. Bioanalytical Testing Services Market by Geography
1.2.4.1. Global Bioanalytical Testing Services Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterβs Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Bioanalytical Testing Services Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Bioanalytical Testing Services Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Bioanalytical Testing Services Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Bioanalytical Testing Services Major Manufacturers in 2017
CHAPTER 4. BIOANALYTICAL TESTING SERVICES MARKET BY TYPE
4.1. Global Bioanalytical Testing Services Revenue By Molecule Type
4.2. Large Molecule
4.2.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
4.2.3. Immunoassays
4.2.4. LC-MS Studies
4.2.5. Others
4.3. Small Molecule
4.3.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
CHAPTER 5. BIOANALYTICAL TESTING SERVICES MARKET BY APPLICATION
5.1. Global Bioanalytical Testing Services Revenue By Test Type
5.2. ADME
5.2.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.2.3. In-Vitro
5.2.4. In-Vivo
5.3. PD
5.3.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.4. PK
5.4.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.5. Bioequivalence
5.5.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.6. Bioavailability
5.6.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
5.7. Others
5.7.1. Market Revenue and Growth Rate, 2015 β 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 β 2026 ($Million)
CHAPTER 6. NORTH AMERICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY
6.1. North America Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 β 2026 ($Million)
6.2. North America Bioanalytical Testing Services Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Bioanalytical Testing Services Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
6.3.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
6.4.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
6.5.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
CHAPTER 7. EUROPE BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY
7.1. Europe Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 β 2026 ($Million)
7.2. Europe Bioanalytical Testing Services Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
7.3.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
7.4.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
7.5.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
7.6.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
7.7.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY
8.1. Asia-Pacific Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 β 2026 ($Million)
8.2. Asia-Pacific Bioanalytical Testing Services Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
8.3.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
8.4.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
8.5.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
8.6.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
8.7.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
8.8.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
CHAPTER 9. LATIN AMERICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY
9.1. Latin America Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 β 2026 ($Million)
9.2. Latin America Bioanalytical Testing Services Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
9.3.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
9.4.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
9.5.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
CHAPTER 10. MIDDLE EAST BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY
10.1. Middle East Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 β 2026 ($Million)
10.2. Middle East Bioanalytical Testing Services Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
10.3.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
10.4.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
10.5.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
CHAPTER 11. AFRICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY
11.1. Africa Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 β 2026 ($Million)
11.2. Africa Bioanalytical Testing Services Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
11.3.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
11.4.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Molecule Type, 2015 β 2026 ($Million)
11.5.2. Market Revenue and Forecast By Test Type, 2015 β 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. PSC
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. SGS SA
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Toxikon, Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. The Intertech group
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Pace Analytical Services, LLC.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. PPD
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. ICON plc
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Covance Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. LabCorp
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Charles River Laboratories International, Inc.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1301
Contact us:
Sheetal k
Email: [email protected]
Phone: +14079154157 | +14089009135